ArticleOncotarget2018

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution.

Joshua N Kellner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.